These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30610540)

  • 61. The addictive potential of cannabis.
    Kaymakçalan S
    Bull Narc; 1981; 33(2):21-31. PubMed ID: 6272922
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
    Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
    Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Palmitoylethanolamide: from endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence.
    Coppola M; Mondola R
    Med Hypotheses; 2013 Oct; 81(4):619-22. PubMed ID: 23896215
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional imaging studies in cannabis users.
    Chang L; Chronicle EP
    Neuroscientist; 2007 Oct; 13(5):422-32. PubMed ID: 17901252
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana.
    Cermak TL
    J Psychoactive Drugs; 2016; 48(1):31-40. PubMed ID: 26881331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.
    Hindocha C; Lawn W; Freeman TP; Curran HV
    Psychopharmacology (Berl); 2017 Nov; 234(21):3153-3163. PubMed ID: 28733813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cannabis and its derivatives: review of medical use.
    Leung L
    J Am Board Fam Med; 2011; 24(4):452-62. PubMed ID: 21737770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
    Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
    Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of the Cerebellum in Drug Reward: A Review.
    Wang YB; Lan Y
    J Integr Neurosci; 2023 Oct; 22(6):147. PubMed ID: 38176941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of cannabis potency with mental ill health and addiction: a systematic review.
    Petrilli K; Ofori S; Hines L; Taylor G; Adams S; Freeman TP
    Lancet Psychiatry; 2022 Sep; 9(9):736-750. PubMed ID: 35901795
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease.
    Pizzolato K; Thacker D; Toro-Pagán ND; Hanna A; Turgeon J; Matos A; Amin N; Michaud V
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cerebellar thickness changes associated with heavy cannabis use: A 3-year longitudinal study.
    Wang Y; Zuo C; Xu Q; Hao L
    Addict Biol; 2021 May; 26(3):e12931. PubMed ID: 32575152
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution.
    Dotson S; Johnson-Arbor K; Schuster RM; Tervo-Clemmens B; Evins AE
    Addiction; 2022 Sep; 117(9):2371-2373. PubMed ID: 35322899
    [No Abstract]   [Full Text] [Related]  

  • 76. Smoke Alarm.
    Wickelgren I
    Science; 2023 Sep; 381(6661):936-940. PubMed ID: 37651516
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cocaine promotes oxidative stress and microglial-macrophage activation in rat cerebellum.
    López-Pedrajas R; Ramírez-Lamelas DT; Muriach B; Sánchez-Villarejo MV; Almansa I; Vidal-Gil L; Romero FJ; Barcia JM; Muriach M
    Front Cell Neurosci; 2015; 9():279. PubMed ID: 26283916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.
    Chadwick B; Miller ML; Hurd YL
    Front Psychiatry; 2013 Oct; 4():129. PubMed ID: 24133461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Motor Adaptation Impairment in Chronic Cannabis Users Assessed by a Visuomotor Rotation Task.
    Herreros I; Miquel L; Blithikioti C; Nuño L; Rubio Ballester B; Grechuta K; Gual A; Balcells-Oliveró M; Verschure P
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31323815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alcohol & cannabinoid co-use: Implications for impaired fetal brain development following gestational exposure.
    Rouzer SK; Gutierrez J; Larin KV; Miranda RC
    Exp Neurol; 2023 Mar; 361():114318. PubMed ID: 36627039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.